| 000 | 01065 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517204357.0 | ||
| 264 | 0 | _c20190527 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/s41416-018-0017-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMouw, Kent W | |
| 245 | 0 | 0 |
_aFrom checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activation. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _c04 2018 |
||
| 300 |
_a933-935 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAtaxia Telangiectasia Mutated Proteins |
| 650 | 0 | 4 | _aB7-H1 Antigen |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xgenetics |
| 650 | 0 | 4 | _aCheckpoint Kinase 1 |
| 650 | 0 | 4 | _aDNA |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 |
_aProtein Kinases _xgenetics |
| 700 | 1 | _aKonstantinopoulos, Panagiotis A | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 118 _gno. 7 _gp. 933-935 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41416-018-0017-x _zAvailable from publisher's website |
| 999 |
_c28171369 _d28171369 |
||